Evidence-first health & aging science Newsletter
Live Well News Live Well News
Home
Longevity
Biological age & clocksLongevity drugsHealthspan & lifestyleCellular aging
Nutrition
Diet patternsProtein & macrosFasting & timingGut & microbiome
Supplements
Vitamins & mineralsPerformance & longevity compoundsHerbals & botanicalsSupplement safety
Fitness
Strength & muscleCardio & VO2 maxHIIT & intervalsMobility & recovery
Sleep
Sleep durationRegularity & circadianQuality & disordersNaps & light
Brain
Cognition & memoryDementia & Alzheimer'sMood & mental healthStress & focus
Metabolic
Weight & obesityGLP-1 & weight-loss drugsBlood sugar & diabetesCholesterol & heart

Tag

GLP-1

Page 2 of 2

A single white oval tablet on a pale blue background
News

A daily weight-loss pill hit 10% in a mid-stage trial

A Lancet phase 2 trial of 310 adults found the oral GLP-1 drug elecoglipron produced up to 10.5% weight loss in 26 weeks against 0.6% on placebo, with no injections and no food restrictions.

Jul 26, 2026
A person holding a blue medical injection pen indoors
News

New drug kept muscle on while weight-loss jabs stripped it

A Nature Medicine trial of 102 adults found adding the antibody apitegromab to tirzepatide cut lean-mass loss by 1.9 kilograms over 24 weeks, without slowing total weight loss.

Jul 25, 2026
A semaglutide injection pen resting on a surface
News

Semaglutide slowed measures of biological aging in a small trial

Researchers reanalyzed a 32-week trial of semaglutide in 84 adults and found the drug slowed several DNA-based clocks of biological aging. The aging analysis was exploratory, and the group studied was specific.

Jul 17, 2026
Search